CORCEPT THERAPEUTICS INC (CORT:NASDAQ)
$77.49 4.16 (5.673%)
Analysed CORCEPT THERAPEUTICS INC (CORT:NASDAQ) News Sources
June 2026 Growth Stocks With High Insider Ownership
04-06-2026
yahoo.com
Growth Companies With High Insider Ownership And Up To 30% Return On Equity
05-06-2026
yahoo.com
Why Is United Therapeutics (UTHR) Down 3.8% Since Last Earnings Report?
05-06-2026
yahoo.com
Top Growth Companies With Insider Ownership In June 2026
05-06-2026
yahoo.com
Corcept Presents New Data at ADA: Improved Outcomes in Patients Receiving a GLP-1 with Difficult-to-Control Type 2 Diabetes and Hypercortisolism Treated with Korlym®
06-06-2026
yahoo.com
Insider Favorites High Growth Companies June 2026
08-06-2026
yahoo.com
CORT Stock Rises 42% in a Month: Here's What You Should Know
08-06-2026
yahoo.com
3 Growth Companies With High Insider Ownership Seeing Up To 94% Earnings Growth
08-06-2026
yahoo.com
3 Growth Stocks With High Insider Ownership And 29% Revenue Growth
09-06-2026
yahoo.com
ATRenew And Two Insider-Favored Growth Stocks To Watch
09-06-2026
yahoo.com
What is the current price of CORCEPT THERAPEUTICS INC (CORT:NASDAQ)?
The current price of CORCEPT THERAPEUTICS INC (CORT:NASDAQ) is $77.49.
CORCEPT THERAPEUTICS INC (CORT:NASDAQ) absolute price change since previous trading day?
The absolute price change of CORCEPT THERAPEUTICS INC (CORT:NASDAQ) since the previous trading day is $4.16.
CORCEPT THERAPEUTICS INC (CORT:NASDAQ) percentage price change since previous trading day?
The percentage price change of CORCEPT THERAPEUTICS INC (CORT:NASDAQ) since the previous trading day is 5.673%.
What is the most recent average sentiment score for CORCEPT THERAPEUTICS INC (CORT:NASDAQ)?
The most recent average sentiment score for CORCEPT THERAPEUTICS INC (CORT:NASDAQ) is 81 out of 100.
What is the most recent average sentiment for CORCEPT THERAPEUTICS INC (CORT:NASDAQ)?
The most recent sentiment for CORCEPT THERAPEUTICS INC (CORT:NASDAQ) is .
SEC-8K** Filing Available For CORCEPT THERAPEUTICS INC (CORT:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.